Other Income & Expense
Other Non-Cash Items
Pfizer Other Non-Cash Items decreased by 20.5% to $93.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 332.5%, from -$40.00M to $93.00M. Over 2 years (FY 2023 to FY 2025), Other Non-Cash Items shows a downward trend with a -63.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Frequent or large adjustments may indicate volatility in non-operating areas or aggressive accounting estimates.
Detailed definition
Aggregated non-cash items that impact net income but do not involve the movement of cash, such as asset impairments, non...
Peer comparison
Commonly found in the 'Adjustments to reconcile net income' section of the cash flow statement.
Metric ID:
cat_other_noncash_income_expenseHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.01B | $543.00M | -$815.00M | -$455.00M | -$211.00M | -$99.00M | $416.00M | $427.00M | $2.75B | $151.00M | -$411.00M | $715.00M | $1.81B | -$40.00M | $101.00M | $292.00M | $117.00M | $93.00M |
| QoQ Change | — | -46.4% | -250.1% | +44.2% | +53.6% | +53.1% | +520.2% | +2.6% | +543.6% | -94.5% | -372.2% | +274.0% | +152.4% | -102.2% | +352.5% | +189.1% | -59.9% | -20.5% |
| YoY Change | — | — | — | -144.9% | -138.9% | +87.9% | +191.4% | +302.4% | — | +252.5% | -198.8% | +67.4% | -34.3% | -126.5% | +124.6% | -59.2% | -93.5% | +332.5% |
Range-$815.00M – $2.75B
CAGR-43.0%
Avg YoY Growth+40.2%
Median YoY Growth+16.6%
Current Streak2 quarters decline
Other Non-Cash Items at Other Companies
Frequently Asked Questions
- What is Pfizer's other non-cash items?
- Pfizer (PFE) reported other non-cash items of $93.00M in Q1 2026.
- How has Pfizer's other non-cash items changed year-over-year?
- Pfizer's other non-cash items increased by 332.5% year-over-year, from -$40.00M to $93.00M.
- What is the long-term trend for Pfizer's other non-cash items?
- Over 2 years (2023 to 2025), Pfizer's other non-cash items has grown at a -63.3% compound annual growth rate (CAGR), from $3.49B to $470.00M.
- What does other non-cash items mean?
- Miscellaneous non-cash gains or losses that affect reported earnings.